Keeler Thomas Management LLC Purchases New Shares in Encompass Health Corporation $EHC

Posted by Brian Himes on Sep 1st, 2026

Keeler Thomas Management LLC purchased a new position in shares of Encompass Health Corporation (NYSE:EHC – Free Report) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 36,694 shares of the company’s stock, valued at approximately $3,709,000. Encompass Health makes up 1.3% of Keeler Thomas Management LLC’s holdings, making the stock its 17th largest holding.

Other institutional investors have also recently added to or reduced their stakes in the company. Ancora Advisors LLC boosted its position in Encompass Health by 13.7% in the 2nd quarter. Ancora Advisors LLC now owns 105,258 shares of the company’s stock valued at $10,639,000 after buying an additional 12,720 shares during the last quarter. Benjamin Edwards Inc. increased its position in shares of Encompass Health by 4.6% during the second quarter. Benjamin Edwards Inc. now owns 9,118 shares of the company’s stock worth $922,000 after acquiring an additional 397 shares during the last quarter. Van ECK Associates Corp lifted its stake in shares of Encompass Health by 3.1% in the second quarter. Van ECK Associates Corp now owns 87,158 shares of the company’s stock worth $8,810,000 after acquiring an additional 2,641 shares in the last quarter. Beacon Pointe Advisors LLC acquired a new position in shares of Encompass Health in the second quarter worth about $2,110,000. Finally, United Capital Financial Advisors LLC purchased a new position in Encompass Health in the second quarter valued at about $351,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Down 0.3%

NYSE:EHC opened at $120.51 on Tuesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.19 and a current ratio of 1.19. The company has a market capitalization of $11.89 billion, a price-to-earnings ratio of 19.63, a price-to-earnings-growth ratio of 2.45 and a beta of 0.72. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The stock has a 50-day simple moving average of $113.64 and a 200 day simple moving average of $107.27.

Encompass Health (NYSE:EHC – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.57 billion. During the same quarter in the prior year, the firm posted $1.40 earnings per share. Encompass Health’s revenue for the quarter was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Sell-side analysts predict that Encompass Health Corporation will post 6.08 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. Encompass Health’s dividend payout ratio is currently 12.38%.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 8,906 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the sale, the executive vice president directly owned 75,041 shares of the company’s stock, valued at approximately $9,451,413.95. This represents a 10.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Mark J. Tarr sold 173,148 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the transaction, the chief executive officer owned 267,814 shares in the company, valued at approximately $33,602,622.58. The trade was a 39.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Barclays lifted their price objective on Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. UBS Group increased their target price on Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Leerink Partners set a $152.00 price target on shares of Encompass Health in a research report on Friday, May 22nd. TD Cowen lifted their price target on shares of Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Finally, Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, August 16th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $148.71.

Check Out Our Latest Stock Analysis on Encompass Health

Encompass Health Profile

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.